Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taro Pharmaceutical Industries Ltd. Ordinary Shares (NY:TARO)

42.97 UNCHANGED
Last Price Updated: 7:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Taro Pharmaceutical Industries Ltd. Ordinary Shares

< Previous 1 2 3 Next >
Taro to Release Third Quarter Results on January 24, 2023
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Provides Results for September 30, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Pharmaceutical Indus's Earnings: A Preview
Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Taro to Release Second Quarter Results on October 27, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro Pharmaceutical Indus: Q1 Earnings Insights
Taro Pharmaceutical Indus (NYSE:TARO) reported its Q1 earnings results on Wednesday, July 27, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For January 27, 2022
Companies Reporting Before The Bell • SAP (NYSE:SAP) is estimated to report quarterly earnings at $1.87 per share on revenue of $9.10 billion. •... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 479 stocks made new 52-week lows. 
Via Benzinga
Taro Provides Results for December 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For January 24, 2023
Companies Reporting Before The Bell • GATX (NYSE:GATX) is expected to report quarterly earnings at $1.44 per share on revenue of $327.63 million. 
Via Benzinga
Taro Pharmaceutical Indus's Earnings Outlook
 
Via Benzinga
Earnings Scheduled For October 27, 2022
Companies Reporting Before The Bell • Janus Henderson Gr (NYSE:JHG) is expected to report quarterly earnings at $0.48 per share on revenue of $494.27 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 429 stocks made new 52-week lows. 
Via Benzinga
Taro Provides Results for the Quarter Ended June 30, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Taro to Release First Quarter Results on July 27, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. 
Via Benzinga
Taro Provides Results for the Year Ended March 31, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 94 companies set new 52-week lows. 
Via Benzinga
Taro Pharmaceutical Indus Earnings Preview
Taro Pharmaceutical Indus (NYSE:TARO) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More
Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support. 
Via Benzinga
Earnings Scheduled For May 26, 2022
Companies Reporting Before The Bell • American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million. 
Via Benzinga
Taro to Announce Full Year Results on May 26, 2022
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
On Friday, 213 companies hit new 52-week lows. 
Via Benzinga
Taro to Acquire Alchemee From Galderma
From Galderma
Via Business Wire
10 Biggest Price Target Changes For Monday
Keybanc cut the price target on The Sherwin-Williams Company (NYSE: SHW) from $394 to $335. Sherwin-Williams shares rose 1.6% to close at $287.70 on Friday. 
Via Benzinga
The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Taro Pharmaceutical: Q3 Earnings Insights
Taro Pharmaceutical Indus (NYSE:TARO) reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM. Here's what investors need to know about the... 
Via Benzinga
Taro Provides Results for December 31, 2021
From Taro Pharmaceutical Industries Ltd.
Via Business Wire
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.